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Introduction
Globally, modern biotechnology is now a little over three decades old (Baltimore, 2008). Having gone past the 
infancy stage it is now in its maturing phase of striving to 
achieve its agenda for the millennium, namely to heal,  feed, 
fuel  and  clean the world. In Malaysia, the industry lags 
behind achievements by the major global players (Ahmad 
Zaharudin, 2005). However, significant growth has 
occurred during the current Ninth Malaysia Plan (9MP) 
primarily due to strong political will. There has been a 
substantive increase in commitment of resources to support 
the National Biotechnology Policy (NBP) launched in April 
2005 (Abdullah, 2005). The budget allocation for Science, 
Technology and Innovation (STI) more than doubled (Table 
1) between 8MP and 9MP (Ninth Malaysia Plan, 2006),  and 
has   accordingly  encouraged  significant  growth  of  the 
industry. Biotech Corp reports that 92 BioNexus 
companies with a total approved investment of RM1.3 billion 
have already been established (Iskandar, 2009).   Without   a 
doubt, it is the Government that drives the Biotechnology 
Industry in Malaysia.
It is against such a scenario that this report, on foresight of 
the needs for the biotechnology industry, is presented as an 
appropriate framework towards strengthening postgraduate 
programmes   geared   to   achieve   research   excellence,  as 
envisaged for Malaysia (Malaysia and the Knowledge 
Economy: Building a World-Class Higher Education System, 
2007) that will in turn impact on developing the national 
biotechnology industry. What is required is to introduce 
postgraduates to the Blue Ocean Strategy (Kim and 
Mauborgne, 2005) in their research training so that they will 
be the catalyst for further development of the biotechnology 
industry and compliment one of MoHE’s Strategic Plans, 
which  is  to  generate  100,000  world  class  Science  and 
Technology doctorates within 15 years (Ministry of Higher 
Education, 2005).
 What	is	the	Future	for	Biotechnology?
The global market is predicted to expand to reach a value 
of USD1.76  trillion  by  2050  (Beyond Border: The Global 
Biotechnology Report, 2008)! If Malaysia aims to harness 
even 0.01 per cent of this market it will amount to a total 
value  of  USD176  billion  by  2050!  Based  on  a  survey 
conducted by Ernst and Young in 2002, the global 
biotechnology  industry  is  set  to  move forward 
significantly in four major fields, namely human 
therapeutics, diagnostics, agriculture, and industrial with 
the prime mover being in healthcare where a larger than 
three-fold increase is expected to occur by 2010 (Figure 1), 
while agricultural and industrial biotechnology will more 
than double in value. The prognosis is therefore, very good 
for growth of the industry.
While Malaysia needs to take note of these global trends, 
R&D training should be directed primarily towards working 
on  local  solutions  to  regional  and  global  problems.  The 
abundant natural resources are there to provide the raw 
material from which innovative new solutions may be 
derived. There are three main areas of focus for 
development of the biotech industry in the country, as stated 
in the NBP (Ahmad Zaharudin, 2005; Abdullah, 2005). These 
are Agribiotechnology, Healthcare-related Biotechnology 
and Industrial Biotechnology. Malaysia’s Biotech strategy is 
to  responsibly  exploit  its  mega  biodiversity  of  plants, 
animals and microbes in order to create new economic 
opportunities for wealth creation and social well-being of 
its people, through better health, food, fibre and fuel, while 
judiciously conserving natural resources and the 
environment. The targets set by the NBP are to create by 
the year 2020, 280,000 jobs in the biotech sector as well as to 
establish at least 400 biotechnology companies and to attract 
RM270 million per annum in investments.
Table  1:	 	 Budget	 	 expenditure	 	 and	 	 allocation	 	 for	
S&T&Innovation	(2001-2010)
8MP 9MP
(RM	millions)
R&D 926.6 1,581.6
Technology Acquisition 70.7 142.6
Commercialisation of Technology 267.5 1,843.3
S&T Human Resource Development & 
Awareness
123.1 650.6
S&T Infrastructure 1,950.0 1,035.1
Total	Allocation 2,337.9 5,253.1
Source: 9MP Doc., Economic Planning Unit, 2006-2010
Figure 1:	Global	biotechnology	industry
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The	Biotechnology	Industry	in	Malaysia	
The current status of the Biotechnology Sector vis a vis 
Human Capital Development, R&D activity and Industry, as 
summerised in Table 2, shows that biotechnology presence 
in the country is quite limited. Forty-three institutes help 
to train man-power for the sector, while only 95 entities are 
actively engaged in the biotechnology-related businesses 
(Biotech Clusters, March 2009).
This situation is unsatisfactory. A new paradigm 
promulgated by MoHE is for “A People-led Economy” 
(Ministry of Higher Education, 2006), the rational being 
that researchers with in-depth knowledge will be able to 
generate new technology platforms to innovate new 
products (“brain power versus brawn power”!!). The 
process flow will then proceed smoothly through the  route 
of  R&D        Technology        Innovation        Funding 
            Market.
All R&D activities require funding. In developed countries, 
funding is almost equally supported by public as well as 
private enterprise (Beyond Border: The Global Technology 
Report, 2006). However, in developing countries less than 
one per cent of R&D funding comes from the private sector. 
In Malaysia, this is especially so for the   fledging biotech 
industry (Ahmad Zaharudin, 2005). As such, it is initiatives 
by  the  Government  that  have  stimulated  growth  of  the 
industry. In particular, two policy documents present the 
foresight framework for the Biotechnology industry, namely 
Chapter 6 on Biotechnology, in the 9MP (Ninth Malaysia 
Plan  2006-2010)  and  the  NBP  document  of  April  2005 
(Abdullah, 2005). Research and development as well as 
commercialisation of biotechnology-related science have 
been programmed to  develop in the following three major 
areas:   Agricultural   Biotechnology,   Healthcare - related
Biotechnology and Industrial Biotechnology, with a 
supportive   role   from   Bioinformatics.   Research   in 
Biotechnology began more than two decades ago and 
reasonable expertise is now available. Arising from this 
and present developments in the industry, it is timely to 
take stock on the status of R&D activity in these areas. The 
anticipated developments in the short-to-medium term as 
well as the medium-to-long term are set out in Table 3. 
Table 3 outlines in general terms, the specific areas where 
current research and development in biotechnology is on-
going and what probably lies ahead. The specifics need to be 
carefully developed to ensure knowledge-based economic 
returns. Current strengths need to be capitalised on and new 
innovative   approaches   sort   to   solve   national   issues. 
Primarily,  these  include:  wealth  creation,  food  security, 
alternate/renewable energy, environmental degradation, 
water  resource  management,  health  and  wellness  of  the 
people. Blue Ocean Strategies (Kim and Mauborgne, 2005) 
need to be developed to address these within the framework 
of  what  is  already  available  in  terms  of  resources  and 
knowledge banks. 
In particular, since Malaysia is globally recognised as a 
country that has built up an impressive knowledge-bank in 
plantation crops, the tools of modern biotechnology should 
be judiciously used on these crops for potentially gainful 
economic returns. The crops of interest include oil palm, 
rubber, coco, and rice as well as horticultural crops like 
tropical fruits, flowers and vegetables. In Animal 
Biotechnology, attention should be on the fledging 
livestock industry in cows, goats, the established swine 
and a robust poultry industry. Aquaculture and marine 
biotechnology for tropical fishes and  marine  organisms 
(including seaweeds)  should  be developed further so that 
new industrial and food-based products can be introduced.
Although the Healthcare Industry is receiving a lot of 
support globally, its R&D has focused on diseases and 
issues relevant to temperate countries (Beyond Borders: 
The Global Technology Report 2006; 2008). It is time for 
Malaysia to address R&D issues pertaining to local and 
regional scourges and health-related problems e.g. dengue, 
typhoid, cholera, tuberculosis. The long-term focus  should 
be  to  also  develop  innovative products from our wide 
biodiversity as viable solutions to address health and well-
being issues. Indigenous knowledge in traditional foods and 
remedies should be documented and researched on. It would 
provide a conduit to new intellectual property with potential 
for  the  start  of  a  green - gold economy in Malaysia. In the 
short-term, customising vaccines and diagnostic kits for local 
applications is providing important value-added products.
Industrial biotechnology readily draws upon innovation 
arising   from   the   knowledge - base   in   Agricultural 
Biotechnology  and  Healthcare  and  Medical - related 
Biotechnology. Energy and environmental issues will 
see new products such as biofuels, and environmentally 
friendly-technologies for pollution control and water and 
resource management develop so long as researchers are 
suitably trained to handle these new challenges. Expanding 
downstream  processing  of  produce  such  as  rice  and 
plantation crops, herbals, fruits and vegetables should also 
stimulate the food industry with value-added products for 
Table 2:	Entities	in	the	Malaysian	biotechnology	sector
Institutes	for	Human	Capital	Development	
and	R&D	Training
Number
Universities
Public 15
Private 15
Research	Institutes 13
Biotech	Companies	and	Related	Activities*
Agriculture 21
Healthcare 28
Industrial 3
Bioinformatics 9
R&D 5
Incubators 24
Others 5
* Includes 13 GLCs (Government-linked companies)
Source: Biotech Corp (Biotech Clusters, 2009)
BULLETIN    National Higher Education Research Institute (IPPTN)
the local and international market. The Nation’s various 
culinary customs provide numerous possibilities for 
innovative developments that could help local foods 
penetrate into global markets. The possibilities are countless 
for the ingenious mind!
Postgraduate	Training	Programmes	for	Biotechnology
“People are the same around the world; free them and they 
start expressing their individual creativity” (Baltimore, 2008). 
If that is the case then, it is essential that the teaching and 
training curriculum, especially at the tertiary level (inclusive 
of postgraduate training) should be especially liberating and 
should stimulate critical thinking and ingenuity in order to 
encourage  new  discoveries  and  new  innovations.  The 
industry is especially in need of such scientists. 
The brick-and-mortar to build a solid foundation must 
still be a bedrock of relevant basic information essential to 
successfully mould the graduate into his field of choice. 
Table 3 indicates that the exposure should be varied 
Table 3:	Foresight	for	Biotechnology	Industry	–	Focus	areas	(2006-2020)
Area Short-to-Medium	Term	(2006-2012) Medium-to-Long	Term	(2012-2020)
Agricultural
Biotechnology
Clonal propagation of selected horticultural, 
plantation and forestry crops
Clonal propagation of commercially useful recalcitrant 
plants and new crops (e.g. for biofuels, biopharmaceuticals, 
biopharming)
Innovative seed production technologies Cryopreservation and artificial seed technology
Improvement of selected livestock and poultry 
through in vitro technologies
Transgenic livestock with genes that add value (e.g. disease 
resistant, better meat quality)
Crop improvement by conventional methods Crop improvement by molecular breeding and transgenic 
technology
Aquaculture of selected ornamental and 
commercial fish, prawns and other aquatic 
organisms
Aquaculture of transgenic fish for disease and pest control; 
improved nutritional/food value
Transgenic production of selected crops with 
genes for pest and/or disease resistance/tolerance
Production of selected transgenic crops with value-added 
qualities, e.g. nutritionally enhanced or better quality; 
enhanced postharvest longevity; reduced chemical and 
other inputs (e.g. water, fungicides)
Food production from down-stream processing of 
fresh produce (e.g. edible oils, fruits, vegetables) 
Food processing from new, value-added transgenics and 
non-transgenics (e.g. heart-healthy cooking oils; orphan 
crops)
Halal food production and development of 
biomarkers
Halal food bio-validation and certification
- Genomics, proteomics of selected plants and animals; gene 
mining to unravel gene regulation of novel and useful 
characteristics
Healthcare	
Biotechnology
Development of diagnostic kits vaccines and other 
biologics for major infectious tropical diseases
Development of new biopharmaceuticals, nutraceuticals 
and cosmeceuticals from natural resources, especially 
plants used as traditional/complementary medicines, or 
health products
Herbal product development and quality 
characteristics
Systems biology to understand mode of action of selected 
herbal plant products
Biomarkers for major diseases and health-related 
problems in Malaysia; association with ethnicity
Proteomics, genomics and systems biology of major 
illnesses and diseases
Bioinformatics of genes associated with major 
diseases and illnesses
Pharmacogenomics and personalised medicine
Stem cell banking technology Stem cell science; tissue engineering
Industrial	
Biotechnology
Bioremediation of biological, industrial and 
environmental wastes
Development of biocatalysts for selected industrial 
applications
Feed production from natural resources and 
biological wastes
Recombinant technology to harness useful microbes for 
bioremediation and selected industrial processes
Down-stream processing of selected fruits and 
plant products
Production of recombinant proteins for food and feed 
preparation
Biofuel from edible crops Biofuel from non-edible crops
Development of clean air and water technology Development of biosensors for industrial applications (e.g. 
environmental pollution)
Bioreactors for food and feed industry Recombinant technology for use in selected bioreactor 
systems
Special industrial production systems e.g. for 
cultivation of mushrooms; seaweeds
New biomaterials for industrial applications; 
nanobiotechnology
- Genomics of selected microbes useful for industrial 
applications
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enough to enable the Malaysian postgraduate student of 
biotechnology to delve into R&D areas relevant to 
Agricultural Biotechnology, Healthcare and/or Industrial 
Biotechnology, as these are the strategic areas projected for 
biotechnology development in the country. Postgraduate 
biotechnology programmes should have embedded in them 
a good balance of the basic and applied sciences, whether 
the programme is project- or course work-based, for it is 
basic science that makes the leap to produce the 
breakthrough concepts. Additionally, an exposure to the 
main elements of good entrepreneurship is also essential 
since   discoveries   and   innovations   in   biotechnology 
eventually find a home in a commercial environment. 
Finally, training in critical thinking that is out-of-the-box 
and directed to innovative solutions will ensure that the 
postgraduates will be able to play a vital role in rapid 
development of the biotechnology industry in the country.
Without doubt, the building of science and technology 
capability is a long-term effort and several developing 
countries are rapidly moving forward in following this 
agenda (Baltimore, 2008). Countries with the political will to 
support it in a sustainable manner by high quality human 
capital development, commitment of adequate resources 
and the implementation of harmonious regulatory regimes 
will no doubt reap the benefits of working on local solutions 
to global problems. The country can then rightfully claim a 
place among the developed nations of the world!
Summary
The Biotechnology Industry is at an early phase of 
development in Malaysia.
The primary objective of biotechnology development is 
for wealth creation and social well-being.
The primary driver is the Government.
There has been significant growth since the launch of 
the National Biotechnology Policy in 2005 and the Ninth 
Malaysia Plan (2006-2010).
The Industry revolves around Agricultural 
Biotechnology, Healthcare-related Biotechnology and 
Industrial Biotechnology.
•
•
•
•
•
Forty-three institutes are involved in Human Capital and 
R&D training for the biotechnology industry.
At least 95 companies are engaged in biotechnology- 
related activities.
The Biotechnology Industry requires postgraduates with 
high knowledge content and good R&D skills in relevant 
areas pertinent to the industry.
R&D focus in biotechnology should be to look for local 
solutions to regional and global problems, by effective 
team-work.
An R&D priority should be to draw on available strengths 
and expertise in the agricultural and plantation sectors.
Innovation and new product/technology development 
efforts should focus on indigenous resources among 
plants, animals and microbes.
Particular research focus should be given to achieve food 
security, develop non-food-based biofuels, remedies 
for tropical diseases, new and innovative products as 
nutraceuticals, cosmeceuticals and biopharmaceuticals 
and a clean environment.
Training postgraduates towards research excellence and 
industrial relevance in biotechnology can be realised if 
postgraduates are exposed to R&D handled via a Blue 
Ocean Strategy that is fuelled by a relevant amount of 
basic research.
Basic entrepreneurship training is essential for biotech-
nology graduates.
Well-trained postgraduates who also have good 
communication skills will help to drive forward the 
biotechnology industry in the country.
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“Training	postgraduates	
towards	research	excellence	
and	industrial	relevance	in	
biotechnology,	can	be	
realised	if	postgraduates	are	
exposed	to	R&D	handled	via	
a	Blue	Ocean	Strategy	that	is	
fuelled	by	a	relevant	amount	
of	basic	research.”
